60505-6050 BORTEZOMIB

Product NDC:

60505-6050

Brand Name:

BORTEZOMIB

Generic Name:

Bortezomib

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: BORTEZOMIB

Strength: 3.5

Unit: mg/1

Packages:

Code: 60505-6050-04

Description: 1 VIAL in 1 CARTON (60505-6050-4) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Effective Date: May 2, 2022

Discontinued: Dec. 31, 2028

SEER*Rx Category:

Chemotherapy

Major Class:

Proteasome Inhibitor

Minor Class:

26S

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox